BIO-Key International Inc (BKYI) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
BIO-Key International Inc stock (BKYI) is currently trading at $0.58. BIO-Key International Inc PS ratio (Price-to-Sales) is 0.99. Analyst consensus price target for BKYI is $2.00. WallStSmart rates BKYI as Sell.
- BKYI PE ratio analysis and historical PE chart
- BKYI PS ratio (Price-to-Sales) history and trend
- BKYI intrinsic value — DCF, Graham Number, EPV models
- BKYI stock price prediction 2025 2026 2027 2028 2029 2030
- BKYI fair value vs current price
- BKYI insider transactions and insider buying
- Is BKYI undervalued or overvalued?
- BIO-Key International Inc financial analysis — revenue, earnings, cash flow
- BKYI Piotroski F-Score and Altman Z-Score
- BKYI analyst price target and Smart Rating
BIO-Key International Inc
📊 No data available
Try selecting a different time range
Smart Analysis
BIO-Key International Inc (BKYI) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
BIO-Key International Inc (BKYI) Key Strengths (2)
Paying less than $1 for every $1 of annual revenue
Trading at 1.08x book value, attractively priced
Supporting Valuation Data
BIO-Key International Inc (BKYI) Areas to Watch (6)
Company is destroying shareholder value
Losing money on operations
Revenue declining -27.70%, a shrinking business
Company is losing money with a negative profit margin
Very low institutional interest at 4.89%
Micro-cap company with very limited liquidity and high volatility
BIO-Key International Inc (BKYI) Detailed Analysis Report
Overall Assessment
This company scores 26/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 2 register as strengths (avg 9.0/10) while 6 fall into concern territory (avg 0.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book. Valuation metrics including Price/Sales (0.99), Price/Book (1.08) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Growth concerns include Revenue Growth at -27.70%, which may limit upside. Profitability pressure is visible in Return on Equity at -137.70%, Operating Margin at -57.60%, Profit Margin at -67.30%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -137.70% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -27.70% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
BKYI Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
BKYI's Price-to-Sales ratio of 0.99x sits near its historical average of 1.05x (0th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 11% below its historical high of 1.11x set in Mar 2026, and 0% above its historical low of 0.99x in Mar 2026.
Compare BKYI with Competitors
Top SECURITY & PROTECTION SERVICES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for BIO-Key International Inc (BKYI) · INDUSTRIALS › SECURITY & PROTECTION SERVICES
The Big Picture
BIO-Key International Inc is in a turnaround phase, with management focused on restoring profitability. Revenue reached 6M with 28% decline year-over-year. The company is currently unprofitable, posting a -67.3% profit margin.
Key Findings
Revenue contracted 28% YoY. Worth determining whether this is cyclical or structural.
The company is unprofitable with a -67.3% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Sector dynamics: monitor SECURITY & PROTECTION SERVICES industry trends, competitive moves, and regulatory changes that could impact BIO-Key International Inc.
Bottom Line
BIO-Key International Inc is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About BIO-Key International Inc(BKYI)
NASDAQ
INDUSTRIALS
SECURITY & PROTECTION SERVICES
USA
BIO-key International, Inc., develops and markets biometric fingerprint identification technology, enterprise-ready identity access management solutions, and software solutions for commercial, government, and educational clients in the United States and internationally. The company is headquartered in Wall, New Jersey.